After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidiary is facing further reprimand from the U.S. regulator. | After a site visit by FDA ...
If you’re reading JellyFil reviews, you’re probably past the ad and into the part that actually matters: does this thing work, and is it worth what it costs? Low energy that creeps in gradually, ...
The U.S. Food and Drug Administration (FDA) recently announced a pilot program for "One-Day Inspectional Assessments," a new ...
Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares, are among the ...
On June 29, 2026, the U.S. Food and Drug Administration (FDA) published a notice of proposed rulemaking (NPRM) titled “Establishment Registration ...
FDA names companies domestic drug manufacturing pilot participants to enhance early regulatory engagement and streamline review processes.
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...
Posts claimed federal officials "upgraded" the recall to the highest level, meaning there's a "reasonable probability of ...
Seven firms were selected for a two-phase FDA program linking new US manufacturing facilities to planned NDA/BLA/ANDA filings or supplements, targeting supply needs and unmet medical needs. Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results